- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $9.67M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $16.43M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $9.5M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $18.13M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $20.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $118.84M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $127.64M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $128.5M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $146.39M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $61.66M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $78.69M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $152.54M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $174.56M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 6.76M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.7M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $9.13M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $72.74M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $82.76M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$2.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$2.10 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $13.48M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$14.22M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.82M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $81.28M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $38.76M |
| Revenue | Q1 2025 · Mar 31, 2024 | $120.05M |